IA
ARKG icon

Insight Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Insight Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-14,237
Closed -$338K – 283
2024
Q4 		$338K Sell
14,237
-2,996
-17% -$73.7K 0.06% 206
2024
Q3 		$441K Sell
17,233
-3,207
-16% -$81.7K 0.08% 176
2024
Q2 		$480K Sell
20,440
-4,391
-18% -$111K 0.09% 159
2024
Q1 		$714K Sell
24,831
-4,803
-16% -$144K 0.14% 114
2023
Q4 		$972K Buy
+29,634
New +$806K 0.21% 85
2023
Q2 		– Sell
-16,307
Closed -$490K – 288
2023
Q1 		$490K Sell
16,307
-7,230
-31% -$224K 0.12% 147
2022
Q4 		$650K Sell
23,537
-7,542
-24% -$239K 0.23% 115
2022
Q3 		$1.02M Sell
31,079
-1,774
-5% -$65.1K 0.4% 61
2022
Q2 		$1.3M Sell
32,853
-3,453
-10% -$121K 0.44% 52
2022
Q1 		$1.67M Sell
36,306
-4,217
-10% -$201K 0.5% 45
2021
Q4 		$2.48M Sell
40,523
-4,682
-10% -$324K 0.73% 28
2021
Q3 		$3.56M Sell
45,205
-3,008
-6% -$252K 1.06% 16
2021
Q2 		$4.07M Sell
48,213
-592
-1% -$50.3K 1.28% 14
2021
Q1 		$4.34M Buy
48,805
+978
+2% +$97K 1.37% 9
2020
Q4 		$4.46M Buy
+47,827
New +$3.81M 1.69% 6

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Insight Advisors's ARKG Position: Q1 2025 in Review

Insight Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2025, closing a stake of 14,237 shares — an estimated $338K sold.

Insight Advisors first reported a position in ARKG in Q4 2020 and held it in 15 quarters. The position peaked at $4.46M in Q4 2020. 214 funds tracked by Wall St. Rank hold ARKG as of Q1 2025.

  • Insight Advisors reported no remaining ARK Genomic Revolution ETF position as of Q1 2025 after selling out during the quarter.
  • Insight Advisors sold 14,237 ARK Genomic Revolution ETF shares in Q1 2025, an estimated $338K.
  • Insight Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 15 quarters.
  • Insight Advisors's ARK Genomic Revolution ETF position peaked at $4.46M in Q4 2020.
  • 214 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2025.

Based on Insight Advisors's 13F filing for Q1 2025, filed 11 Apr 2025.